The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: “Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer”. Molecules 2017, 22, 582, pii: E582

Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer

(2017) John I. Toohey   MOLECULES

Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease

(2016) Xin Xu et al.   JAMA Internal Medicine

Lower Hydrogen Sulfide Is Associated with Cardiovascular Mortality, Which Involves cPKCβII/Akt Pathway in Chronic Hemodialysis Patients

(2015) Su-Juan Feng et al.   BLOOD PURIFICATION

Correlation of Lower Concentrations of Hydrogen Sulfide with Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy

(2014) Han Li et al.   BLOOD PURIFICATION

The Role of Homocysteine-Lowering B-Vitamins in the Primary Prevention of Cardiovascular Disease

(2014) Balazs Debreceni et al.   Cardiovascular Therapeutics

US Renal Data System 2013 Annual Data Report

(2013) Allan J. Collins et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Updating the Relationship between Hyperhomocysteinemia Lowering Therapy and Cardiovascular Events

(2012) Xiaoshu Cheng   Cardiovascular Therapeutics

Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study

(2011) Franziska Marti et al.   BMC PUBLIC HEALTH

Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy

(2011) Julio C.B. Ferreira et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Homocysteine Lowering in End-Stage Renal Disease

(2010) Lawrence de Koning et al.   CIRCULATION

Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy

(2010) Andrew A. House et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Homocysteine as a Risk Factor for Cardiovascular Disease in Patients Treated by Dialysis: A Meta–analysis

(2009) Judith Heinz et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hyperhomocysteinemia in Uremia-A Red Flag in a Disrupted Circuit

(2009) Alessandra F. Perna et al.   SEMINARS IN DIALYSIS

5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients

(2008) Giuseppe Cianciolo et al.   AMERICAN JOURNAL OF NEPHROLOGY

Mice deficient in PKCβ and apolipoprotein E display decreased atherosclerosis

(2008) Evis Harja et al.   FASEB JOURNAL